[Hormonal studies and clinical observations in patients with threatening abortion or premature birth, respectively treated with depot-17-alpha-hydroxyprogesterone-caproate].
D000033:Abortion, Threatened / Q000188:drug therapy*; D000328:Adult; D002208:Caproates / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004964:Estriol / Q000652:urine; D004967:Estrogens / Q000096:biosynthesis; D005260:Female; D005865:Gestational Age; D006801:Humans; D006908:Hydroxyprogesterones / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine; D011379:Prognosis
D002208:Caproates; D004967:Estrogens; D006908:Hydroxyprogesterones; D004964:Estriol; D011276:Pregnanediol
Hormonale Untersuchungen und klinische Beobachtungen an Kranken mit drohender Fehl-bzw. Frühgeburt, behandelt mittels 17- -Hydroxyprogesteron-Capronat-Depot.